Skip to content

Clinical trials

Observational Breast Neoplasms trials in Saudi Arabia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Phase: Observational Country / region: Saudi Arabia Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20091
20101
20121
20141
20162
20172
20212
20232
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting2
Suspended2
Unknown status2
Not yet recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Guard Health Affairs4
AstraZeneca2
Hoffmann-La Roche2
Pfizer2
Assiut University1
King Abdulaziz University1
Mansoura University1
Novartis1
Novartis Pharmaceuticals1
SWOG Cancer Research Network1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms16
Neoplasm Metastasis2
Breast Neoplasms, Male1
Carcinoma, Non-Small-Cell Lung1
Lung Neoplasms1
Multiple Myeloma1
Neoplasms1
Neoplasms, Plasma Cell1
Prostatic Neoplasms1
Small Cell Lung Carcinoma1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.